ZK-261991 is an orally bioavailable VEGFR tyrosine kinase inhibitor with an IC50 of 5 nM for VEGFR2. References: Deniz Hos, et al. Inflammatory Corneal (Lymph)angiogenesis Is Blocked by VEGFR-Tyrosine Kinase Inhibitor ZK 261991, Resulting in Improved Graft Survival after Corneal Transplantation. Investigative Ophthalmology & Visual Science May 2008, Vol.49, 1836-1842.

纯度：≥98%

CAS：886563-25-3